Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors

by Erhao Zhang, Jieyi Gu, Hanmei Xu
Published 2018-01-01

Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12

by Xiaowei Chi, Peiwei Yang, Erhao Zhang, Jieyi Gu, Hui Xu, Mengwei Li, Xinmei Gao, Xin Li, Yinan Zhang, Hanmei Xu, Jialiang Hu
Published 2019-08-01

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide

by Erhao Zhang, Jieyi Gu, Jianpeng Xue, Chenyu Lin, Chen Liu, Mengwei Li, Jingchao Hao, Sarra Setrerrahmane, Xiaowei Chi, Weiyan Qi, Jialiang Hu, Hanmei Xu
Published 2018-03-01

Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

by Erhao Zhang, Peiwei Yang, Jieyi Gu, Heming Wu, Xiaowei Chi, Chen Liu, Ying Wang, Jianpeng Xue, Weiyan Qi, Qingbo Sun, Shengnan Zhang, Jialiang Hu, Hanmei Xu
Published 2018-08-01